Literature DB >> 8314000

Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development.

D P Huynh1, T Nechiporuk, S M Pulst.   

Abstract

Mutations in the NF1 gene may cause developmental abnormalities and the formation of a variety of tumors of neural crest origin in humans. The NF1 gene codes for a large protein, neurofibromin (nf), which is structurally and functionally related to yeast and human ras-GTPase-activating proteins (ras-GAPs). Recently, two transcripts coding for type I and type II nf with different ras-GAP activity have been identified. Since ras proteins do not appear to be significantly regulated during mouse development, we examined if differential expression of neurofibromins may provide evidence for a role of nfs in regulating ras-mediated cell proliferation and differentiation. Nfs were expressed as early as E8. At E11 a marked increase of NF1 transcripts occurred and was associated with expression of nfs in all tissues. Type I and type II nfs each showed a different time course of expression and tissue localization, with type II nf present mainly from E8 through E10, although in the heart type II nf was present at E12. In some tissues such as heart and dorsal root ganglia rapid increases and decreases of nfs were detected related to differentiation of these tissues. These results are consistent with a role of nfs in regulating ras-mediated cell proliferation and differentiation during development and support distinct functional roles for type I and type II nfs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8314000     DOI: 10.1006/dbio.1994.1052

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  19 in total

Review 1.  Neurofibromatosis type 1: modeling CNS dysfunction.

Authors:  David H Gutmann; Luis F Parada; Alcino J Silva; Nancy Ratner
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

2.  Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.

Authors:  Y Zhu; M I Romero; P Ghosh; Z Ye; P Charnay; E J Rushing; J D Marth; L F Parada
Journal:  Genes Dev       Date:  2001-04-01       Impact factor: 11.361

3.  Neurofibromatosis type 1 alternative splicing is a key regulator of Ras signaling in neurons.

Authors:  Melissa N Hinman; Alok Sharma; Guangbin Luo; Hua Lou
Journal:  Mol Cell Biol       Date:  2014-04-07       Impact factor: 4.272

4.  Neurofibromatosis type 1 alternative splicing is a key regulator of Ras/ERK signaling and learning behaviors in mice.

Authors:  Hieu T Nguyen; Melissa N Hinman; Xuan Guo; Alok Sharma; Hiroyuki Arakawa; Guangbin Luo; Hua Lou
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

5.  Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation.

Authors:  Yuan Zhu; Takayuki Harada; Li Liu; Mark E Lush; Frantz Guignard; Chikako Harada; Dennis K Burns; M Livia Bajenaru; David H Gutmann; Luis F Parada
Journal:  Development       Date:  2005-12       Impact factor: 6.868

Review 6.  Diverse molecular functions of Hu proteins.

Authors:  M N Hinman; H Lou
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

7.  Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.

Authors:  Michaela Livia Bajenaru; Yuan Zhu; Nicolé M Hedrick; Jessica Donahoe; Luis F Parada; David H Gutmann
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

8.  Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels.

Authors:  D A Largaespada; J D Shaughnessy; N A Jenkins; N G Copeland
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Assessment of pain and itch behavior in a mouse model of neurofibromatosis type 1.

Authors:  Daniel E O'Brien; Daniel S Brenner; David H Gutmann; Robert W Gereau
Journal:  J Pain       Date:  2013-04-09       Impact factor: 5.820

10.  The neurofibromatosis type I pre-mRNA is a novel target of CELF protein-mediated splicing regulation.

Authors:  Victoria A Barron; Hui Zhu; Melissa N Hinman; Andrea N Ladd; Hua Lou
Journal:  Nucleic Acids Res       Date:  2009-10-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.